Elicera Therapeutics AB (ELIC) — Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

Elicera Therapeutics AB (ELIC) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow (Skr3.50 Million) in capital expenditures (Skr1.00K). Check ELIC goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

Skr3.50 Million

SEK

Capital Expenditures

Skr1.00K

SEK

Data as of

Dec 2023

Most recent filing

Annual Capital Reinvestment Ratio for Elicera Therapeutics AB (None–None)

Year-by-year Capital Reinvestment Ratio for Elicera Therapeutics AB from None to None. See how much free cash does Elicera Therapeutics AB generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow